porfiromycin
Term · Oncology and biomedicine · MLC-T-ONC-006823
A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called anticancer antibiotics.
An N-methyl derivative of the antineoplastic antibiotic mitomycin C isolated from the bacterium Streptomyces ardus and other Streptomyces bacterial species. Bioreduced porfiromycin generates oxygen radicals and alkylates DNA, producing interstrand cross-links and single-strand breaks, thereby inhibiting DNA synthesis. Porfiromycin is preferentially toxic to hypoxic cells.
| Identifier | MLC-T-ONC-006823 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | methyl mitomycin C; methyl mitomycin; Methylmitomycin; porfiromycine; porphyromycin |
| References | NCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-006823",
"term": "porfiromycin",
"field": "Oncology and biomedicine",
"definitions": [
"A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called anticancer antibiotics.",
"An N-methyl derivative of the antineoplastic antibiotic mitomycin C isolated from the bacterium Streptomyces ardus and other Streptomyces bacterial species. Bioreduced porfiromycin generates oxygen radicals and alkylates DNA, producing interstrand cross-links and single-strand breaks, thereby inhibiting DNA synthesis. Porfiromycin is preferentially toxic to hypoxic cells."
],
"synonyms": [
"methyl mitomycin C",
"methyl mitomycin",
"Methylmitomycin",
"porfiromycine",
"porphyromycin"
],
"references": [
"NCI Dictionary of Cancer Terms",
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/porfiromycin/"
}
Record 13,500 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.